021-51111890
购物车（）
sales@molnova.cn
ent-Ezetimibe
CAS No. 1376614-99-1
ent-Ezetimibe ( ent-SCH 58235 )
产品货号. M26200 CAS No. 1376614-99-1
Ezetimibe is a Niemann-Pick C1-like1 (NPC1L1) inhibitor, and is a potent Nrf2 activator.ent-Ezetimibe (ent-SCH 58235) is the RRS-enantiomer of Ezetimibe. Ezetimibe is a potent cholesterol absorption inhibitor.?
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥3078 | 有现货 |
|
| 10MG | ￥4560 | 有现货 |
|
| 25MG | ￥7185 | 有现货 |
|
| 50MG | ￥9963 | 有现货 |
|
| 100MG | ￥13527 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称ent-Ezetimibe
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Ezetimibe is a Niemann-Pick C1-like1 (NPC1L1) inhibitor, and is a potent Nrf2 activator.ent-Ezetimibe (ent-SCH 58235) is the RRS-enantiomer of Ezetimibe. Ezetimibe is a potent cholesterol absorption inhibitor.?
-
产品描述Ezetimibe is a Niemann-Pick C1-like1 (NPC1L1) inhibitor, and is a potent Nrf2 activator.ent-Ezetimibe (ent-SCH 58235) is the RRS-enantiomer of Ezetimibe. Ezetimibe is a potent cholesterol absorption inhibitor.?
-
同义词ent-SCH 58235
-
通路Others
-
靶点Other Targets
-
受体AChE; BChE
-
研究领域——
-
适应症——
化学信息
-
CAS Number1376614-99-1
-
分子量409.4
-
分子式C24H21F2NO3
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO[C@H](CC[C@H]1[C@@H](N(C1=O)c1ccc(F)cc1)c1ccc(O)cc1)c1ccc(F)cc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Deng QH, Wadepohl H, Gade LH. The synthesis of a new class of chiral pincer ligands and their applications in enantioselective catalytic fluorinations and the Nozaki-Hiyama-Kishi reaction. Chemistry. 2011 Dec 23;17(52):14922-8.
产品手册
关联产品
-
Rutaevin 7-acetate
Rutaevin 7-acetate is a natural product for research related to life sciences.
-
NSC622608
NSC622608 is a small-molecule ligand for V-domain Ig suppressor of T-cell activation (VISTA) which is an immune checkpoint that affects the ability of T-cells to attack tumors.
-
Fosravuconazole L-ly...
FosravuconazoleL-lysine ethanolate is a broad-spectrum antifungal agent. In Japan, it is approved for the treatment of onychomycosis, a fungal infection of the nail. It is a prodrug that is converted into ravuconazole.
